Abstract:The physiologic actions of retinoic acids (RAs) are mediated through RA receptors (RARs) and retinoid X receptors (RXRs). The RARalpha gene has drawn particular attention because it is the common target in all chromosomal translocations in acute promyelocytic leukemia (APL), a unique model in cancer research that responds to the effect of RA. In the great majority of patients with APL, RARalpha is fused to the PML gene as a result of the t(15;17) translocation. Three distinct types of PML-RARalpha transcripts, long (L), short (S), and variant (V), were identified. The V-type is characterized by truncation of exon 6 of PML and in some cases by the insertion of a variable "spacer" sequence between the truncated PML and RARalpha mRNA fusion partners, although the precise mechanisms underlying formation of the V-type transcript remain unclear. To get further insights into the molecular basis of the t(15;17), we sequenced the entire genomic DNA region of RARalpha. Of note, all previously reported "spacer" sequences in V-type transcripts were found in intron 2 of the RARalpha gene and most of these sequences were flanked by gt splice donor sites. In most cases, these "cryptic" coding sequences maintained the ORF of the chimeric transcript. Interestingly, two cases with a relatively long spacer sequence showed APL cellular and clinical resistance to RA treatment. In these cases, the aberrant V-type PML-RARalpha protein displayed increased affinity to the nuclear corepressor protein SMRT, providing further evidence that RA exerts the therapeutic effect on APL through modulation of the RAR-corepressor interaction. Finally, among patients with the L- or S-type PML-RARalpha fusion transcript, some consensus motifs were identified at the hotspots of the chromosome 17q breakpoints within intron 2 of RARalpha, strengthening the importance of this intron in the molecular pathogenesis of APL.

TTRAP is a novel PML nuclear bodies-associated protein.

Cellular Protein TTRAP Interacts with HIV-1 Integrase to Facilitate Viral Integration.

PML protein isoforms and the RBCC/TRIM motif

The 68-Kda Telomeric Repeat Binding Factor 1 (Trf1)-Associated Protein (TAP68) Interacts with and Recruits TRF1 to the Spindle Pole During Mitosis

PML3 Interacts with TRF1 and is Essential for ALT-associated PML Bodies Assembly in U2OS Cells.

PML3 Orchestrates the Nuclear Dynamics and Function of TIP60

TRAIP regulates replication fork recovery and progression via PCNA

Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression

Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway

Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer

PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia

Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia

A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor

Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription

Pml/Rar Alpha Targets Promoter Regions Containing Pu.1 Consensus And Rare Half Sites In Acute Promyelocytic Leukemia

Variant-Type Pml-Rar Alpha Fusion Transcript In Acute Promyelocytic Leukemia: Use Of A Cryptic Coding Sequence From Intron 2 Of The Rar Alpha Gene And Identification Of A New Clinical Subtype Resistant To Retinoic Acid Therapy

RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB Signaling*

TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways

Tblr1 Fuses to Retinoid Acid Receptor Alpha in A Variant T(3;17)(Q26;Q21) Translocation of Acute Promyelocytic Leukemia

Construction of Yeast Two-hybrid System of TTRAP

Nuclear pore protein TPR associates with lamin B1 and affects nuclear lamina organization and nuclear pore distribution